Core Insights - Invivyd, Inc. has announced a partnership with Olympic ski champion Lindsey Vonn to enhance public understanding of antibodies and their role in disease prevention through a national multimedia education campaign set to launch in Spring 2026 [1][11]. Company Overview - Invivyd, Inc. is a biopharmaceutical company focused on providing protection against serious viral infectious diseases, starting with SARS-CoV-2. The company utilizes a proprietary integrated technology platform to develop and adapt antibodies [5]. Partnership Details - Lindsey Vonn will act as the spokesperson for Invivyd's educational initiative, aiming to connect antibody science with health and wellness discussions. The campaign will focus on educating the public about antibodies and their importance in preventing infectious diseases [3][11]. - The collaboration is expected to make antibody science more relatable and trustworthy, especially in the context of ongoing national discussions about infectious disease prevention [4]. Campaign Objectives - The educational campaign aims to empower the American public by simplifying the understanding of health and antibody protection, making it less intimidating [4][11]. - The campaign is strategically timed to follow Vonn's recent comeback to competitive skiing, which is anticipated to draw significant public interest [11].